
TY  - JOUR
TI  - Poster Presentations
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 28
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.12363_2
DO  - doi:10.1111/jgh.12363_2
SP  - 23
EP  - 693
PY  - 2013
ER  - 

TY  - JOUR
TI  - Posters
JO  - FEBS Open Bio
JA  - FEBS Open Bio
VL  - 9
IS  - S1
SN  - 2211-5463
UR  - https://doi.org/10.1002/2211-5463.12675
DO  - doi:10.1002/2211-5463.12675
SP  - 65
EP  - 431
PY  - 2019
ER  - 

TY  - JOUR
TI  - Medicolegal Section Program Abstract
JO  - ANZ Journal of Surgery
VL  - 80
IS  - s1
SN  - 1445-1433
UR  - https://doi.org/10.1111/j.1445-2197.2010.05298_11.x
DO  - doi:10.1111/j.1445-2197.2010.05298_11.x
SP  - A50
EP  - A50
PY  - 2010
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 28
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.12363_1
DO  - doi:10.1111/jgh.12363_1
SP  - 1
EP  - 22
PY  - 2013
ER  - 

TY  - JOUR
AU  - Judith Radin, M.
AU  - Yu, Ming-Jiun
AU  - Stoedkilde, Lene
AU  - Lance Miller, R.
AU  - Hoffert, Jason D.
AU  - Frokiaer, Jorgen
AU  - Pisitkun, Trairak
AU  - Knepper, Mark A.
TI  - Aquaporin-2 regulation in health and disease
JO  - Veterinary Clinical Pathology
JA  - Vet Clin Pathol
VL  - 41
IS  - 4
SN  - 0275-6382
UR  - https://doi.org/10.1111/j.1939-165x.2012.00488.x
DO  - doi:10.1111/j.1939-165x.2012.00488.x
SP  - 455
EP  - 470
KW  - Exosomes
KW  - polyuria
KW  - syndrome of inappropriate antidiuretic hormone excess
KW  - transcription
KW  - vasopressin
PY  - 2012
AB  - Abstract Aquaporin-2 (AQP2), the vasopressin-regulated water channel of the renal collecting duct, is dysregulated in numerous disorders of water balance in people and animals, including those associated with polyuria (urinary tract obstruction, hypokalemia, inflammation, and lithium toxicity) and with dilutional hyponatremia (syndrome of inappropriate antidiuresis, congestive heart failure, cirrhosis). Normal regulation of AQP2 by vasopressin involves 2 independent regulatory mechanisms: (1) short-term regulation of AQP2 trafficking to and from the apical plasma membrane, and (2) long-term regulation of the total abundance of the AQP2 protein in the cells. Most disorders of water balance are the result of dysregulation of processes that regulate the total abundance of AQP2 in collecting duct cells. In general, the level of AQP2 in a collecting duct cell is determined by a balance between production via translation of AQP2 mRNA and removal via degradation or secretion into the urine in exosomes. AQP2 abundance increases in response to vasopressin chiefly due to increased translation subsequent to increases in AQP2 mRNA. Vasopressin-mediated regulation of AQP2 gene transcription is poorly understood, although several transcription factor-binding elements in the 5? flanking region of the AQP2 gene have been identified, and candidate transcription factors corresponding to these elements have been discovered in proteomics studies. Here, we review progress in this area and discuss elements of vasopressin signaling in the collecting duct that may impinge on regulation of AQP2 in health and in the context of examples of polyuric diseases.
ER  - 

TY  - JOUR
TI  - Abstracts from the American Society of Andrology 44th Annual Conference
JO  - Andrology
VL  - 7
IS  - S1
SN  - 2047-2919
UR  - https://doi.org/10.1111/andr.12624
DO  - doi:10.1111/andr.12624
SP  - 1
EP  - 110
PY  - 2019
ER  - 

TY  - JOUR
AU  - Ferioli, Martina
AU  - Zauli, Giorgio
AU  - Maiorano, Patrizia
AU  - Milani, Daniela
AU  - Mirandola, Prisco
AU  - Neri, Luca M.
TI  - Role of physical exercise in the regulation of epigenetic mechanisms in inflammation, cancer, neurodegenerative diseases, and aging process
JO  - Journal of Cellular Physiology
JA  - J Cell Physiol
VL  - 234
IS  - 9
SN  - 0021-9541
UR  - https://doi.org/10.1002/jcp.28304
DO  - doi:10.1002/jcp.28304
SP  - 14852
EP  - 14864
KW  - aging
KW  - cancer
KW  - epigenetics
KW  - inflammation
KW  - physical exercise
PY  - 2019
AB  - Abstract The genetic heritage for decades has been considered to respond only to gene promoters or suppressors, with specific roles for oncogenes or tumor-suppressor genes. Epigenetics is progressively attracting increasing interest because it has demonstrated the capacity of these regulatory processes to regulate the gene expression without modifying gene sequence. Several factors may influence epigenetics, such as lifestyles including food selection. A role for physical exercise is emerging in the epigenetic regulation of gene expression. In this review, we resume physiological and pathological implications of epigenetic modification induced by the physical activity (PA). Inflammation and cancer mechanisms, immune system, central nervous system, and the aging process receive benefits due to PA through epigenetic mechanisms. Thus, the modulation of epigenetic processes by physical exercise positively influences prevention, development, and the course of inflammatory and cancer diseases, as well as neurodegenerative illnesses. This growing field of studies gives rise to a new role for PA as an option in prevention strategies and to integrate pharmacological therapeutic treatments.
ER  - 

TY  - JOUR
AU  - Ahmad, Wasim
AU  - Ali, Abuzer
AU  - Ali, Amena
AU  - Khan, Sana
AU  - Khan, Saba
AU  - Husain, Ibraheem
TI  - Upcoming diagnostic biomarkers with promising prospects in neurological disorders
JO  - Clinical and Experimental Pharmacology and Physiology
JA  - Clin Exp Pharmacol Physiol
VL  - 47
IS  - 3
SN  - 0305-1870
UR  - https://doi.org/10.1111/1440-1681.13216
DO  - doi:10.1111/1440-1681.13216
SP  - 347
EP  - 356
KW  - network approach
KW  - neurodiagnostic marker specific neurodiagnostic biomarker
KW  - neurological disorders
KW  - non-specific neurodiagnostic biomarker
KW  - personalized medication
PY  - 2020
AB  - Abstract An exponential increase in the prevalence of neurological disorders requires substantial steps to be taken for their prevention and treatment. Neurodiagnostic biomarkers are gaining momentum presently in order to enhance the diagnostic accuracy of neurodegenerative disorders, to precisely assess their advancement and to monitor the efficiency of therapeutic interventions. Therefore, the primary focus of the present review is the recent development in this field of neurodiagnostic biomarkers, and the current state of biomarker exploration in the context of various neurodegenerative diseases. This review encompasses an updated and detailed account of specific (?-Amyloid, Tau and Phospho-tau 181, Tar-DNA binding protein-43, Progranulin, a-synuclein, Clusterin, etc) and non-specific (genetic, synaptic, inflammatory and coagulation) neurodiagnostic biomarkers and the recent advances in this growing field. This comprehensive review also suggests the utilization of neurodiagnostic markers in network approaches and personalized medication that will eventually improvise the existing diagnostic and therapeutic complexities of neurodiagnostic biomarkers.
ER  - 

TY  - JOUR
TI  - 17th International Congress of Immunology, 19–23 October 2019, Beijing, China
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 49
IS  - S3
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.201970400
DO  - doi:10.1002/eji.201970400
SP  - 1
EP  - 2223
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Colorectal Disease
JA  - Colorectal Dis
VL  - 21
IS  - S3
SN  - 1462-8910
UR  - https://doi.org/10.1111/codi.14775
DO  - doi:10.1111/codi.14775
SP  - 33
EP  - 128
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Sessions Monday/Tuesday
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 134
IS  - S1
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.13188
DO  - doi:10.1111/jnc.13188
SP  - 102
EP  - 242
PY  - 2015
ER  - 

TY  - JOUR
TI  - GLIA Bilbao 2015: Abstracts Oral Presentations, Posters, Indexes
JO  - Glia
JA  - Glia
VL  - 63
IS  - S1
SN  - 0894-1491
UR  - https://doi.org/10.1002/glia.22870
DO  - doi:10.1002/glia.22870
SP  - E76
EP  - E469
PY  - 2015
ER  - 

TY  - JOUR
TI  - ASBMR 30th Annual Meeting SU001–SU504
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 23
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650231305
DO  - doi:10.1002/jbmr.5650231305
SP  - S243
EP  - S373
PY  - 2008
ER  - 

TY  - JOUR
AU  - Ericson, Katrin Rhodes
AU  - Simons, Jonathan W.
AU  - Soule, Howard R.
TI  - The 17th Annual Prostate Cancer Foundation scientific retreat: Meeting report
JO  - The Prostate
JA  - Prostate
VL  - 71
IS  - 15
SN  - 0270-4137
UR  - https://doi.org/10.1002/pros.21378
DO  - doi:10.1002/pros.21378
SP  - 1616
EP  - 1620
KW  - Immuno-Oncology
KW  - genomic rearrangements
KW  - perineural invasion
KW  - caloric restriction
PY  - 2011
AB  - Abstract Annually the Prostate Cancer Foundation (PCF) organizes a scientific retreat to assemble the premier prostate cancer researchers from around the world to share and review the latest progress made in the field and to evaluate future directions. This report highlights some of the most significant advances made in prostate cancer research in 2010 that were presented at the 17th Annual PCF Scientific Retreat. Prostate 71:1616?1620, 2011. ? 2011 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
TI  - American Neurological Association 131st Annual Meeting October 8-11, 2006 Chicago, Illinois
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 60
IS  - 5
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.21027
DO  - doi:10.1002/ana.21027
SP  - 625
EP  - 645
PY  - 2006
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Epilepsia
JA  - Epilepsia
VL  - 56
IS  - S1
SN  - 0013-9580
UR  - https://doi.org/10.1111/epi.13241
DO  - doi:10.1111/epi.13241
SP  - 3
EP  - 263
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Acta Ophthalmologica
JA  - Acta Ophthalmol
VL  - 96
IS  - S260
SN  - 1755-375X
UR  - https://doi.org/10.1111/aos.13736
DO  - doi:10.1111/aos.13736
SP  - 3
EP  - 49
PY  - 2018
ER  - 

TY  - JOUR
TI  - ABSTRACTS—POSTERS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 33
IS  - s1
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2009.00957.x
DO  - doi:10.1111/j.1530-0277.2009.00957.x
SP  - 11A
EP  - 265A
PY  - 2009
ER  - 

TY  - JOUR
TI  - Poster Abstract
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 48
IS  - S1
SN  - 0014-2972
UR  - https://doi.org/10.1111/eci.12926
DO  - doi:10.1111/eci.12926
SP  - 70
EP  - 225
PY  - 2018
ER  - 

TY  - JOUR
TI  - Melanoma 2010 Congress
JO  - Pigment Cell & Melanoma Research
VL  - 23
IS  - 6
SN  - 1755-1471
UR  - https://doi.org/10.1111/j.1755-148X.2010.00767.x
DO  - doi:10.1111/j.1755-148X.2010.00767.x
SP  - 874
EP  - 1004
PY  - 2010
ER  - 
